VIDEO: Treatments for geographic atrophy controversial

ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses the controversy surrounding FDA-approved treatments for geographic atrophy.Two treatments are commercially available, but Kim, professor of ophthalmology at Vanderbilt Eye Institute, said the drugs are invasive and expensive, have side effects, and “don’t provide any meaningful visual